Standout Papers
- Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation. (1987)
Citation Impact
Citing Papers
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease
2007
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
2011
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease with Rabbit Antithymocyte Globulin
2000
Diet and Lifestyle Recommendations Revision 2006
2006 Standout
The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
2006
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes
2006
Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease
2002
Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation
1999
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study
2000
Budd–Chiari syndrome: a review by an expert panel
2003
Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome
2003
Prognostic relevance of ‘early‐onset’ graft‐versus‐host disease following non‐myeloablative haematopoietic cell transplantation
2005
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome
2002
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
2014 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients
2002
Acute graft-vs-host disease
2001
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study
2006
Chronic myelomonocytic leukemia
2002
Diagnosis and management of refractoriness to platelet transfusion
2001
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
2002
Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease
2006
Drug-Induced Hepatotoxicity
2003 Standout
Cytomegalovirus and Lung Transplantation
2004
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Techniques for blood administration in sickle cell patients
2001
Multi-institutional Feasibility Study of a Fast Patient Localization Method in Total Marrow Irradiation With Helical Tomotherapy: A Global Health Initiative by the International Consortium of Total Marrow Irradiation
2014
IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE
1997
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
2009
Vascular disorders of the liver # †
2008 Standout
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Non‐endocrine late complications of bone marrow transplantation in childhood: part II
2002
Is it time to reevaluate methyl balance in humans?
2006
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: Incidence, risk factors, and outcome
1999
Genetics of Type 1 Diabetes
2012
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
2005 StandoutNobel
Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation
2004
Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation
2006
Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation
2000
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience
2006
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Graft-versus-host disease
2009 Standout
Echinocandin antifungal drugs
2003 Standout
Circos: An information aesthetic for comparative genomics
2009 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995
2000
Pathophysiology of Graft-Versus-Host Disease
2006
Acute Kidney Injury in Children and Its Potential Consequences in Adulthood
2012
Type 1 diabetes
2013 Standout
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
A Successful Liver Transplantation for Refractory Hepatic Veno‐Occlusive Disease Originating from Cord Blood Transplantation
2002
Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease
1996
Bone Marrow Transplantation
1994
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants
1998
Childhood Leukemias
1995
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Idarucizumab for Dabigatran Reversal
2015 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Hepatic Venoocclusive Disease in Blood and Bone Marrow Transplantation in Children and Young Adults: Incidence, Risk Factors, and Outcome in a Cohort of 241 Patients
2002
Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia
1997
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Solid Cancers after Bone Marrow Transplantation
1997
Immune intervention in type 1 diabetes
2011
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation
2004
Infection in Solid-Organ Transplant Recipients
2007 Standout
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
2005
Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment
2002
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On†
2010
Transjugular Intrahepatic Portosystemic Shunt for the Management of Severe Venoocclusive Disease Following Bone Marrow Transplantation
1996
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation†
2005
Anemia of Chronic Disease
2005 Standout
Symptoms and Suffering at the End of Life in Children with Cancer
2000 Standout
How I treat refractory acute GVHD
2007
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation
2003
Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant
2003
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
2002
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation
2003
Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system
1995
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)
1995
A Risk Score for Mortality after Allogeneic Hematopoietic Cell Transplantation
2006
Acute Myeloid Leukemia
2015 Standout
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival
2008
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
2004
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
2003
One Chance in a Million: Altruism and the Bone Marrow Registry
2009
CD8+minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells
1999
Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition 1 1Confocal imaging studies were performed in the Confocal Microscopy core of the University of Southern California Center for Liver Disease Research. The authors thank Dr. Carol Gregorio (University of Arizona) for her invaluable advice on actin studies and Peixin Wang for performing part of the gelatin zymography studies.
2003
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial
1989
Incentives and Prosocial Behavior
2006 StandoutNobel
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
2003
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
2008
Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant Recipients
1990
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]
1989
Effect of recombinant human erythropoietin combined with granulocyte/ macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome
2000
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells
2003
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome
2003
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
2007
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]
1989
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Decreased Hepatic Nitric Oxide Production Contributes to the Development of Rat Sinusoidal Obstruction Syndrome
2003
Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?
2000
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor
1994
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation
2001
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
2000
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
Cytokine dysregulation and acute graft-versus-host disease
1992
Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use study
2000
Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
1999
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
2002
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
2007
Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients
1999
Final adult height of patients who received hematopoietic cell transplantation in childhood
2004
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
1998
Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients
1999
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease
1992
World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997
1999 Standout
Risks, Costs, and Alternatives to Platelet Transfusions
1999
Late Effects of Hematopoietic Cell Transplantation Among 10-Year Adult Survivors Compared With Case-Matched Controls
2005
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
2002
Report of an international working group to standardize response criteria for myelodysplastic syndromes.
2000
Hodgkin's lymphoma
2003
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
2002
Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention
2003
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
2004
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
2000
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning
2003
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of Gary Schoch being referenced
Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation.
1987 StandoutNobel
14th International HLA and Immunogenetics Workshop: Report on the HLA component of type 1 diabetes
2007
Albuminuria in Hematopoietic Cell Transplantation Patients: Prevalence, Clinical Associations, and Impact on Survival
2008
Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS‐related acute myeloid leukaemia
1996
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
1992
Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation
2001
Chronic kidney disease in long-term survivors of hematopoietic cell transplant
2007
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
1996
Hepatitis C Virus Infection and Bone Marrow Transplantation: A Cohort Study With 10–Year Follow–Up
1999
Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic Anemia
1989
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
1991
A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- associated CMV infection after marrow transplant [see comments]
1995
Cyclosporine or Cyclosporine Plus Methylprednisolone for Prophylaxis of Graft-Versus-Host Disease: A Prospective, Randomized Trial
1997
Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk factors
2004
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients
1996
Methods for Assessment of Graft-Versus-Host Disease
1998
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment
1990
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome
1993
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients
1996
Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptoms
1994
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
1991
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors
1996
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
1993
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment
1990
Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study
1996
Stem Cell Transplantation for Secondary Acute Myeloid Leukemia: Evaluation of Transplantation as Initial Therapy or Following Induction Chemotherapy
1997
Die Zufuhr von Kreatin und Kreatinin mit Frauenmilch und Säuglingsmilchpräparaten*
1987
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.
1987